Prostate cancer is an exceedingly common disease, affecting 1 in 8 men. When diagnosed early, many can live for years without symptoms. Rather than subject early-disease stage patients to the debilitating side-effects of radiation and surgery, clinic
Veracyte, Inc. , a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance for prostate.
New testing approach improves detection of rare but emerging Powassan virus spread by deer ticks medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a focus on breast cancer, today announced that the first patient has been dosed with Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen, in the Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: Ductal Carcinoma In Situ (R
Pork price in Bacolod City increased to P410 per kilo based on the latest monitoring of the Provincial Veterinary Office.Provincial Veterinarian Dr. Placeda Lem